Darcey M Mccready
Dados Biográficos
| ID | 4238042 |
|---|---|
| NOME | Darcey M Mccready |
| PRENOMES | Darcey M |
| SOBRENOME | Mccready |
| ASSINATURA | MCCREADY D M |
| AFILIAÇÕES | George Washington University |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 6 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 6 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2025 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Correlates of Derived Cannabis Product Awareness, Knowledge, Use, and Use Intentions Among Young Adults
Derived psychoactive cannabis products (DPCPs) are chemically synthesized and intoxicating. Despite their widespread use, factors associated with DPCP use remain largely unknown. We analyzed 2023 survey data among 4,031 U.S. young adults (48.9% past-month cannabis use per study design). Multivariable regressions examined sociodemographics in relation to DPCP awareness (yes/no) and patterns of DPCP knowledge, derived based on latent class analysis…
Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States
26.38, ~50% past-month cannabis use by design) completed an online survey. Multivariable regression assessed sociodemographics, mental health, and adverse childhood events (ACEs) in relation to: (1) past-year psychedelic use; and (2) among those reporting lifetime use: (a) lifetime microdosing and (b) use motives. Lifetime and past-year psychedelic use were 27.7% and 11.9% (commonly psilocybin/amanita, MDMA, and LSD); 48.8% used only for nonmedic…
Cannabis and Psychedelics Among U.S. Young Adults
This study assessed the correlates of cannabis and psychedelic use and legalization support among young adults in the United States (US). Using 2025 data among adults ages 18-34 ( n = 3227), we assessed cannabis and psychedelic message exposure and perceptions, mental health symptoms (Patient Health Questionnaire-4 [PHQ-4]), and adverse childhood experiences (ACEs) in relation to past-6-month cannabis use (40.5%), past-year psychedelic use (11.9%…
Associations Between Cannabis Messaging and Derived Psychoactive Cannabis Product Perceptions, Use, and Use Intentions Among a Sample of US Young Adults
Background Since the 2018 Agricultural Improvement Act, derived intoxicating cannabis products (DICPs) emerged as largely unregulated products; meanwhile, traditional cannabis use has increased. To inform effective prevention, research is needed to assess differences in motives for using cannabis only versus both cannabis and DICPs, as well as use-related consequences.Methods We analyzed survey data (June–November 2023) from 4,031 US young adults…
Profiles of quality of life among US young adult cancer survivors and their associations with potential psychosocial intervention targets of hope and psychological flexibility
Young Adults' Experiences with Cannabis Retailer Marketing and Related Practices
Sem obras proeminentes nesta página.
Associations Between Cannabis Messaging and Derived Psychoactive Cannabis Product Perceptions, Use, and Use Intentions Among a Sample of US Young Adults
Background Since the 2018 Agricultural Improvement Act, derived intoxicating cannabis products (DICPs) emerged as largely unregulated products; meanwhile, traditional cannabis use has increased. To inform effective prevention, research is needed to assess differences in motives for using cannabis only versus both cannabis and DICPs, as well as use-related consequences.Methods We analyzed survey data (June–November 2023) from 4,031 US young adults…
Profiles of quality of life among US young adult cancer survivors and their associations with potential psychosocial intervention targets of hope and psychological flexibility
Young Adults' Experiences with Cannabis Retailer Marketing and Related Practices
Correlates of Derived Cannabis Product Awareness, Knowledge, Use, and Use Intentions Among Young Adults
Derived psychoactive cannabis products (DPCPs) are chemically synthesized and intoxicating. Despite their widespread use, factors associated with DPCP use remain largely unknown. We analyzed 2023 survey data among 4,031 U.S. young adults (48.9% past-month cannabis use per study design). Multivariable regressions examined sociodemographics in relation to DPCP awareness (yes/no) and patterns of DPCP knowledge, derived based on latent class analysis…
Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States
26.38, ~50% past-month cannabis use by design) completed an online survey. Multivariable regression assessed sociodemographics, mental health, and adverse childhood events (ACEs) in relation to: (1) past-year psychedelic use; and (2) among those reporting lifetime use: (a) lifetime microdosing and (b) use motives. Lifetime and past-year psychedelic use were 27.7% and 11.9% (commonly psilocybin/amanita, MDMA, and LSD); 48.8% used only for nonmedic…
Cannabis and Psychedelics Among U.S. Young Adults
This study assessed the correlates of cannabis and psychedelic use and legalization support among young adults in the United States (US). Using 2025 data among adults ages 18-34 ( n = 3227), we assessed cannabis and psychedelic message exposure and perceptions, mental health symptoms (Patient Health Questionnaire-4 [PHQ-4]), and adverse childhood experiences (ACEs) in relation to past-6-month cannabis use (40.5%), past-year psychedelic use (11.9%…
Young adult (6 obras) · Cannabis (4 obras) · Cannabis and Cannabinoid Research (4 obras) · Substance Abuse Treatment and Outcomes (4 obras) · Psychedelics and Drug Studies (3 obras) · Psychiatry (3 obras) · Psychology (3 obras) · Clinical Psychology (2 obras) · Forensic Toxicology and Drug Analysis (2 obras) · Gerontology (2 obras)